COMPASS Pathways has been making waves since its inception, and this year is no exception. The company released its second-quarter financial report and...
Christain Angermayer gave some clarification on PCN-101, atai's ketamine program, hinting at new direction for the compound. The post Christian Angermayer...
Atai noted it was exploring strategic options for the study. The post Atai May Step Away from Ketamine Study After Releasing Positive Results appeared...
Atai announced results from Perception Neuroscience’s Phase 1 intravenous-to-subcutaneous bridging study of PCN-101 (R-ketamine). The post atai Life...
Who won the awards on the final night of the Diggers and Dealers forum in Kalgoorlie and which lithium explorer ... Read More The post Diggers...
Local markets are flat at lunchtime, despite a push among banking stocks and some huge lithium news for Iris Metals. ... Read More The post ASX...
The release of quarterly financial reports over the past few weeks is providing some much-needed insight into the state of the industry. It is becoming...
Source: Clive Maund 08/04/2023 Technical Analyst Clive Maund reviews Awakn Life Sciences Corp.'s 26-month and year-to-date charts to tell you...
FREMONT, CA, Aug. 07, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC)... The post ABVC Corporate Update and CEO’s...
COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, reported...